ACTA PHARMACEUTICA
Acta Pharm. Vol. 61 No. 4 pp. 363-476
Zagreb, December 2011
TABLE OF CONTENTS
ORIGINAL RESEARCH PAPERS
A. M.
Avachat, P. N. Bornare and R. R. Dash
Sustained release microspheres of
ropinirole hydrochloride: Effect of process parameters .363
G. M. Hadad, R. A.
Abdel-Salam and S. Emara
Optimized and validated flow-injection spectrophotometric analysis of topiramate, piracetam and levetiracetam in pharmaceutical formulations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .377
L. Y.
Lyn, H. W. Sze, A.
Rajendran, G. Adinarayana, K. Dua
and S. Garg
Crystal modifications and dissolution rate o piroxicam. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 391
M. A.
Abonassif, M. M. Hefnawy, M. G. Kassem and G. A. E. Mostafa
Determination
of donepezil hydrochloride in human plasma and pharmaceutical formulations by
HPLC with fluorescence detection. . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..403
M. M. Ghorab, F. A. Ragab, H. I. Heiba, M. G. El-Gazzar and M. G. El-Gazzar
Synthesis, in-vitro anticancer screening and radiosensitizing evaluation of some new 4-[3-(substituted)thioureido]-N-(quinoxalin-2-yl)benezenesulfonamide derivatives. . . . . . . . . . .415
SHORT COMMUNICATIONS
P.
Gohil, H. Thakkar, U. Gohil and S. Deshpande
Preliminary studies on the effect of
rebamipide against the trypsin and egg-albumin induced experimental model of
asthma. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . 427
T.
Ali Meer, K. P. Sawant and P. D. Amin
Liquid antisolvent precipitation process
for solubility modulation of bicalutamide . . . . . . .435
S. A. Singh and S. V. Bhat
Antimicrobial potential of 3-hydroxy-2-methylene-3-phenylpropionic acid derivatives . . . 447
T. M.
Sastry and K. Ramakrishna
Assay of lercanidipine hydrochloride in dosage forms using
nucleophilic
substitution reaction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . 457
M.
Zovko Končić, B. Zorc and P. Novak
Macromolecular
prodrugs. XIII. Hydrosoluble conjugates of 17β-estradiol and
estradiol-17β-valerate with polyaspartamide polymer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . .465
BOOK REVIEW. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 473
ACKNOWLEDGEMENT TO REFERRES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 475
INDEX TO VOLUME 61. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I
INSTRUCTIONS TO AUTHORS. . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .XIII